EAM Investors’s Astrana Health ASTH Stock Holding History

EAM Investors’s Portfolio ASTH Stock Details ASTH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-14,227	Closed	-$1.29M	–	391
2021 Q3	$1.29M	Sell	14,227 -10,701	-43%	-$910K	0.22%	229
2021 Q2	$1.57M	Buy	+24,928	New	+$922K	0.24%	210

Other funds holding ASTH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

EAM

Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return

EAM Investors's ASTH Position: Q4 2021 in Review

EAM Investors sold out of Astrana Health (ASTH) in Q4 2021, closing a stake of 14,227 shares — an estimated $1.29M sold.

EAM Investors first reported a position in ASTH in Q2 2021 and held it in 2 quarters. The position peaked at $1.57M in Q2 2021. 149 funds tracked by Wall St. Rank hold ASTH as of Q4 2021.

EAM Investors reported no remaining Astrana Health position as of Q4 2021 after selling out during the quarter.
EAM Investors sold 14,227 Astrana Health shares in Q4 2021, an estimated $1.29M.
EAM Investors first reported a position in Astrana Health in Q2 2021 and held it in 2 quarters.
EAM Investors's Astrana Health position peaked at $1.57M in Q2 2021.
149 funds tracked by Wall St. Rank held Astrana Health as of Q4 2021.

Based on EAM Investors's 13F filing for Q4 2021, filed 11 Feb 2022.